Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Altered macrophage differentiation and immune dysfunction in tumor development.

Antonio Sica1, Vincenzo Bronte

  • 1Istituto Clinico Humanitas, Instituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Rozzano, Italy.

The Journal of Clinical Investigation
|May 4, 2007
PubMed
Summary

Tumors recruit myelomonocytic cells, primarily macrophages, to aid growth through angiogenesis and stroma remodeling. These cells also impair anti-tumor immunity, suggesting new therapeutic targets by modulating this interplay.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transcriptional and Epigenetic Plasticity Drive an Alternative Non-clonal Mechanism of Resistance to <i>Kras</i> <sup>G12D</sup> Inhibition in Pancreatic Cancer.

Cancer communications (London, England)·2026
Same author

c-FLIP as a master regulator of immune homeostasis and disease mechanisms.

Cell death & disease·2026
Same author

The sialic shield of leukemia cells.

Science (New York, N.Y.)·2026
Same author

Gasotransmitters bridging tumor biology and immunity: from pathophysiological insights to therapeutic potential.

Frontiers in immunology·2026
Same author

Longitudinal Comparison of Calprotectin and C-Reactive Protein in Rheumatoid Arthritis: Real-World Evidence Across Three Targeted Therapies.

Diagnostics (Basel, Switzerland)·2026
Same author

A comprehensive longitudinal analysis of the cellular immune response specific to the spike protein in healthcare workers vaccinated against SARS-CoV-2- ORCHESTRA Project.

Frontiers in immunology·2025

Area of Science:

  • Oncology
  • Immunology
  • Cell Biology

Background:

  • Tumors depend on myelomonocytic cells for growth, angiogenesis, and stroma remodeling.
  • Tumor-derived factors drive myelopoiesis and accumulation of these cells, mainly macrophages, at the tumor site.
  • Accumulated myelomonocytic cells can suppress anti-tumor immune responses by causing lymphocyte dysfunction.

Purpose of the Study:

  • To elucidate the role of myelomonocytic cells in tumor growth and immune evasion.
  • To understand the interaction between neoplastic and myelomonocytic cells.
  • To identify novel therapeutic targets within this cellular crosstalk.

Main Methods:

  • Analysis of tumor microenvironment composition.
  • Investigation of tumor-derived factor signaling pathways.

Related Experiment Videos

  • Assessment of myelomonocytic cell function and interaction with lymphocytes.

    • Main Results:

    • Demonstrated sustained myelopoiesis and accumulation of myelomonocytic cells in tumors.
    • Confirmed functional differentiation of these cells into tumor-associated macrophages.
    • Observed induction of lymphocyte dysfunction mediated by these cells.

    Conclusions:

    • Myelomonocytic cells are crucial for tumor growth and immune suppression.
    • Targeting the interplay between tumor and myelomonocytic cells offers a promising therapeutic strategy.
    • Modulating this interaction could enhance anti-tumor immunity and limit tumor progression.